BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33664640)

  • 1. Atrial fibrillation: villain or bystander in vascular brain injury.
    Freedman B; Kamel H; Van Gelder IC; Schnabel RB
    Eur Heart J Suppl; 2020 Nov; 22(Suppl M):M51-M59. PubMed ID: 33664640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.
    Schnabel RB; Haeusler KG; Healey JS; Freedman B; Boriani G; Brachmann J; Brandes A; Bustamante A; Casadei B; Crijns HJGM; Doehner W; Engström G; Fauchier L; Friberg L; Gladstone DJ; Glotzer TV; Goto S; Hankey GJ; Harbison JA; Hobbs FDR; Johnson LSB; Kamel H; Kirchhof P; Korompoki E; Krieger DW; Lip GYH; Løchen ML; Mairesse GH; Montaner J; Neubeck L; Ntaios G; Piccini JP; Potpara TS; Quinn TJ; Reiffel JA; Ribeiro ALP; Rienstra M; Rosenqvist M; Themistoclakis S; Sinner MF; Svendsen JH; Van Gelder IC; Wachter R; Wijeratne T; Yan B
    Circulation; 2019 Nov; 140(22):1834-1850. PubMed ID: 31765261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.
    Kamel H; Okin PM; Longstreth WT; Elkind MS; Soliman EZ
    Future Cardiol; 2015 May; 11(3):323-31. PubMed ID: 26021638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review.
    Kerr B; Brandon L
    Int J Cardiol Heart Vasc; 2022 Dec; 43():101132. PubMed ID: 36246770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Gloekler S; Saw J; Koskinas KC; Kleinecke C; Jung W; Nietlispach F; Meier B
    Int J Cardiol; 2017 Dec; 249():234-246. PubMed ID: 28882323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation.
    Deguchi I; Osada T; Arai N; Takahashi S
    Heart Vessels; 2022 May; 37(5):867-874. PubMed ID: 34797401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding.
    Cimmino G; Loffredo FS; Gallinoro E; Prozzo D; Fabiani D; Cante L; Salerno G; Cappelli Bigazzi M; Golino P
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34063719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Atrium and Embolic Stroke: Myopathy Not Atrial Fibrillation as the Requisite Determinant?
    Sajeev JK; Kalman JM; Dewey H; Cooke JC; Teh AW
    JACC Clin Electrophysiol; 2020 Mar; 6(3):251-261. PubMed ID: 32192674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.
    Potpara TS; Dagres N; Mujović N; Vasić D; Ašanin M; Nedeljkovic M; Marin F; Fauchier L; Blomstrom-Lundqvist C; Lip GY
    Adv Ther; 2017 Feb; 34(2):357-377. PubMed ID: 27933569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry After Embolic Stroke of Undetermined Source.
    Sebasigari D; Merkler A; Guo Y; Gialdini G; Kummer B; Hemendinger M; Song C; Chu A; Cutting S; Silver B; Elkind MSV; Kamel H; Furie KL; Yaghi S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1249-1253. PubMed ID: 28237125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioembolic Stroke.
    Kamel H; Healey JS
    Circ Res; 2017 Feb; 120(3):514-526. PubMed ID: 28154101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation in embolic stroke of undetermined source: role of advanced imaging of left atrial function.
    Chousou PA; Chattopadhyay R; Ring L; Khadjooi K; Warburton EA; Mukherjee T; Bhalraam U; Tsampasian V; Potter J; Perperoglou A; Pugh PJ; Vassiliou VS
    Eur J Prev Cardiol; 2023 Dec; 30(18):1965-1974. PubMed ID: 37431922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review.
    Kotadia ID; Sim I; Mukherjee R; O'Hare D; Chiribiri A; Birns J; Bhalla A; O'Neill M; Williams SE
    J Am Heart Assoc; 2021 Jul; 10(13):e021045. PubMed ID: 34212774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial Cardiopathy and Cryptogenic Stroke.
    Kato Y; Takahashi S
    Front Neurol; 2022; 13():839398. PubMed ID: 35273560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial Fibrillation and Stroke.
    Essa H; Hill AM; Lip GYH
    Card Electrophysiol Clin; 2021 Mar; 13(1):243-255. PubMed ID: 33516402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation.
    Simpson E; Stevenson M; Scope A; Poku E; Minton J; Evans P
    Health Technol Assess; 2013 Aug; 17(36):1-263, v-vi. PubMed ID: 23985296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial Cardiomyopathy: An Unexplored Limb of Virchow's Triad for AF Stroke Prophylaxis.
    Darlington A; McCauley MD
    Front Cardiovasc Med; 2020; 7():11. PubMed ID: 32133372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on atrial fibrillation: focus on stroke risk reduction strategies.
    Potpara T; Jokic V; Medic B; Prostran M; Lip G
    Minerva Med; 2015 Oct; 106(5):259-273. PubMed ID: 26495822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).
    Goldman ME; Pearce LA; Hart RG; Zabalgoitia M; Asinger RW; Safford R; Halperin JL
    J Am Soc Echocardiogr; 1999 Dec; 12(12):1080-7. PubMed ID: 10588784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.